<?xml version="1.0" encoding="UTF-8"?>

<!--L
  Copyright Oracle Inc

  Distributed under the OSI-approved BSD 3-Clause License.
  See http://ncip.github.com/cadsr-cgmdr-nci-uk/LICENSE.txt for details.
L-->

<cgMDR:Enumerated_Value_Domain xmlns:cgMDR="http://www.cancergrid.org/schema/cgMDR" item_registration_authority_identifier="GB-CANCERGRID-CA" data_identifier="E80DDB2C4" version="0.1">
    <cgMDR:administered_item_administration_record>
        <cgMDR:administrative_note/>
        <cgMDR:administrative_status>scheduledForReview</cgMDR:administrative_status>
        <cgMDR:creation_date>2008-02-05</cgMDR:creation_date>
        <cgMDR:effective_date>2008-02-05</cgMDR:effective_date>
        <cgMDR:last_change_date>2008-02-05</cgMDR:last_change_date>
        <cgMDR:registration_status>Recorded</cgMDR:registration_status>
    </cgMDR:administered_item_administration_record>
    <cgMDR:administered_by>GB-CANCERGRID-000007-1</cgMDR:administered_by>
    <cgMDR:registered_by>GB-CANCERGRID-000009-1</cgMDR:registered_by>
    <cgMDR:submitted_by>GB-CANCERGRID-000007-1</cgMDR:submitted_by>
    <cgMDR:having>
        <cgMDR:context_identifier>GB-CANCERGRID-000001-1</cgMDR:context_identifier>
        <cgMDR:containing>
            <cgMDR:language_section_language_identifier>
                <cgMDR:country_identifier>GB</cgMDR:country_identifier>
                <cgMDR:language_identifier>eng</cgMDR:language_identifier>
            </cgMDR:language_section_language_identifier>
            <cgMDR:name>Tumour Response End Treatment Lesion 2</cgMDR:name>
            <cgMDR:definition_text>Classification of response to treatment at the end of the treatment cycles for the 2nd breast lesion</cgMDR:definition_text>
            <cgMDR:preferred_designation>true</cgMDR:preferred_designation>
            <cgMDR:definition_source_reference/>
        </cgMDR:containing>
    </cgMDR:having>
    <cgMDR:typed_by>GB-CANCERGRID-000010-1</cgMDR:typed_by>
    <cgMDR:value_domain_datatype>KRMZ1P97F</cgMDR:value_domain_datatype>
    <cgMDR:value_domain_unit_of_measure>MV3QWZ2YG</cgMDR:value_domain_unit_of_measure>
    <cgMDR:containing permissible_value_identifier="52584E8B6">
        <cgMDR:permissible_value_begin_date>2008-02-05Z</cgMDR:permissible_value_begin_date>
        <cgMDR:value_item>1</cgMDR:value_item>
        <cgMDR:contained_in>E4C22B965</cgMDR:contained_in>
    </cgMDR:containing>
    <cgMDR:containing permissible_value_identifier="B3E42CB27">
        <cgMDR:permissible_value_begin_date>2008-02-05Z</cgMDR:permissible_value_begin_date>
        <cgMDR:value_item>2</cgMDR:value_item>
        <cgMDR:contained_in>235B6B123</cgMDR:contained_in>
    </cgMDR:containing>
    <cgMDR:containing permissible_value_identifier="0A3404382">
        <cgMDR:permissible_value_begin_date>2008-02-05Z</cgMDR:permissible_value_begin_date>
        <cgMDR:value_item>3</cgMDR:value_item>
        <cgMDR:contained_in>5499ABD46</cgMDR:contained_in>
    </cgMDR:containing>
    <cgMDR:containing permissible_value_identifier="08274DAAB">
        <cgMDR:permissible_value_begin_date>2008-02-05Z</cgMDR:permissible_value_begin_date>
        <cgMDR:value_item>4</cgMDR:value_item>
        <cgMDR:contained_in>459B9E4CD</cgMDR:contained_in>
    </cgMDR:containing>
    <cgMDR:containing permissible_value_identifier="0CE6857CB">
        <cgMDR:permissible_value_begin_date>2008-02-05Z</cgMDR:permissible_value_begin_date>
        <cgMDR:value_item>5</cgMDR:value_item>
        <cgMDR:contained_in>7ADC0EE5E</cgMDR:contained_in>
    </cgMDR:containing>
    <cgMDR:representing>GB-CANCERGRID-CA-A5EE04418-0.1</cgMDR:representing>
</cgMDR:Enumerated_Value_Domain>